The Corner Series

One of the most misunderstood provisions in the entire tax code, the Qualified Small Business Stock (QSBS) has been around for more than 30 years. Yet it remained largely dormant — until now.The QSBS is “unlike anything in the code,” says Shahrooz Shahnavaz, a tax partner at McGuireWoods.In this conversation with colleague and host Geoff Cockrell, Shahrooz reviews the history of this unique benefit and puts it into context for today’s M&A deal-makers. Tune in for his insights on the potential 100% exclusion of gain, the structural limits that bar some professions — including healthcare — from qualifying, and the One Big Beautiful Bill Act’s “generous” $15 million per-shareholder, per-company cap.Connect and Learn More☑️ Shahrooz Shahnavaz | LinkedIn☑️ Geoff Cockrell | LinkedIn☑️ McGuireWoods | LinkedIn | Facebook | Instagram | X☑️ Subscribe Apple Podcasts | Spotify | Amazon MusicThis podcast was recorded and is being made available by McGuireWoods for informational purposes only. By accessing this podcast, you acknowledge that McGuireWoods makes no warranty, guarantee, or representation as to the accuracy or sufficiency of the information featured in the podcast. The views, information, or opinions expressed during this podcast series are solely those of the individuals involved and do not necessarily reflect those of McGuireWoods. This podcast should not be used as a substitute for competent legal advice from a licensed professional attorney in your state and should not be construed as an offer to make or consider any investment or course of action.

Home and alternate-site infusion therapy is a highly fragmented market. Just two large players command 35% to 40% market share while more than 800 smaller providers making up the remainder. And that fragmentation is exactly what's drawing private equity interest.Don Hooker, director of research at Bourne Partners, a leading life science investment firm, joins McGuireWoods partner and host Geoff Cockrell to unpack the investment landscape. Don explains that delivering drugs at home or in alternate sites can cost roughly half as much as treatment in an inpatient setting. He also outlines the two main pressures shaping the home infusion space.Tune in for his insights about reimbursement dynamics, labor intensity, drug pricing and “back-end" strategic buyers such as Option Care Health.Connect and Learn More☑️ Don Hooker | LinkedIn☑️ Bourne Partners | LinkedIn☑️ Geoff Cockrell | LinkedIn☑️ McGuireWoods | LinkedIn | Facebook | Instagram | X☑️ Subscribe Apple Podcasts | Spotify | Amazon MusicThis podcast was recorded and is being made available by McGuireWoods for informational purposes only. By accessing this podcast, you acknowledge that McGuireWoods makes no warranty, guarantee, or representation as to the accuracy or sufficiency of the information featured in the podcast. The views, information, or opinions expressed during this podcast series are solely those of the individuals involved and do not necessarily reflect those of McGuireWoods. This podcast should not be used as a substitute for competent legal advice from a licensed professional attorney in your state and should not be construed as an offer to make or consider any investment or course of action.

Ezra Simons, co-founder of Physician Growth Partners and expert in provider services consolidation. He maps how specialties shifted from dermatology to urology, orthopedics and cardiology. He discusses aligning providers and incentives, creative economic structures beyond production pay, alternative buyers like pharma and payers, and why med spas and asset-light models are booming.

Michael Kroin, CEO and managing partner at Physician Growth Partners, brings deep deal experience in provider services. He explores new buyer types entering specialties like eye care and oncology. He explains why geography, state rules, and drug spend steer strategic interest. He outlines how downstream M&A is reopening and why durable provider alignment matters.

Henry Yan, principal at Whistler Capital Partners and healthcare-focused lower middle-market investor. He recalls the grit behind a first fundraise. He discusses sector specialization, using placement agents, and why co-investment matters. He highlights Nashville’s talent, tech-enabled healthcare plays, and which subsectors and investor types are most active.

Rebecca Springer, director of market development at Bailey & Company and former PitchBook journalist, shares a 2026 outlook. She highlights healthcare consumerization and the rise of cash-pay services. Short takes cover scaling affordable consumer health, employer-driven demand via HSAs, and medical equipment servicing as an emerging private equity theme.

“We’re predicting that 2026 will be a bit stronger than 2025 in terms of overall deal activity,” says Rebecca Springer, director of market development at Bailey & Company, a healthcare-dedicated investment banking group.In a three-part installment of the “Corner Series Shorts” format, where McGuireWoods partner and host Geoff Cockrell dives into a narrower topic with experts, Rebecca shares her outlook on 2026.In this episode, Rebecca reviews the outlook for physician practice management (PPM) deals in 2026. She explains why she expects to see a “modest increase” in PPM activity relative to 2025 and shares other insights about the market, including the future of large PPM platforms and the “mixed picture” of dental.Connect and Learn More☑️ Rebecca Springer | LinkedIn☑️ Bailey & Company | LinkedIn | X☑️ Geoff Cockrell | LinkedIn☑️ McGuireWoods | LinkedIn | Facebook | Instagram | X☑️ Subscribe Apple Podcasts | Spotify | Amazon MusicThis podcast was recorded and is for informational purposes only. By accessing this podcast, you acknowledge that Bailey & Co. makes no warranty, guarantee, or representation as to the accuracy or sufficiency of the information featured. The views, information, or opinions expressed during this podcast series are solely those of the individuals involved and do not necessarily reflect those of Bailey & Co. This podcast should not be used as a substitute for competent investment advice from a licensed professional or attorney in your state and should not be construed as an offer to make or consider any investment or course of action.This podcast was recorded and is being made available by McGuireWoods for informational purposes only. By accessing this podcast, you acknowledge that McGuireWoods makes no warranty, guarantee, or representation as to the accuracy or sufficiency of the information featured in the podcast. The views, information, or opinions expressed during this podcast series are solely those of the individuals involved and do not necessarily reflect those of McGuireWoods. This podcast should not be used as a substitute for competent legal advice from a licensed professional attorney in your state and should not be construed as an offer to make or consider any investment or course of action.

“We're predicting that 2026 will be a bit stronger than 2025 in terms of overall deal activity," says Rebecca Springer, director of market development at Bailey & Company, a healthcare-dedicated investment banking group.In the latest installment of the “Corner Series Shorts” format, where host Geoff Cockrell dives into a narrower topic with experts, Rebecca unpacks where the deal activity is landing, why there are opportunities for small and mid-sized employers to self-insure, and what factors are keeping the landscape of cost-containment vendors fragmented. Stay tuned for two more episodes featuring Rebecca coming soon.  Connect and Learn More☑️ Rebecca Springer | LinkedIn☑️ Bailey & Company | LinkedIn | X☑️ Geoff Cockrell | LinkedIn☑️ McGuireWoods | LinkedIn | Facebook | Instagram | X☑️ Subscribe Apple Podcasts | Spotify | Amazon MusicThis podcast was recorded and is for informational purposes only. By accessing this podcast, you acknowledge that Bailey & Co. makes no warranty, guarantee, or representation as to the accuracy or sufficiency of the information featured. The views, information, or opinions expressed during this podcast series are solely those of the individuals involved and do not necessarily reflect those of Bailey & Co. This podcast should not be used as a substitute for competent investment advice from a licensed professional or attorney in your state and should not be construed as an offer to make or consider any investment or course of action.This podcast was recorded and is being made available by McGuireWoods for informational purposes only. By accessing this podcast, you acknowledge that McGuireWoods makes no warranty, guarantee, or representation as to the accuracy or sufficiency of the information featured in the podcast. The views, information, or opinions expressed during this podcast series are solely those of the individuals involved and do not necessarily reflect those of McGuireWoods. This podcast should not be used as a substitute for competent legal advice from a licensed professional attorney in your state and should not be construed as an offer to make or consider any investment or course of action.

Ben Mackay, a Principal at Evolve Capital, dives into the intriguing realm of lower middle-market healthcare, specifically focusing on Medicare home health. He shares how controlling ownership paired with founder retention can create lasting value. With insights on growth opportunities in autism services and specialty pharmacies for pets, he also discusses challenges like workforce shortages and navigating regulatory hurdles. Ben emphasizes rural market strategies and the advantages of scale in home healthcare, showcasing a diverse landscape of emerging opportunities.

As founder and CEO of Nyoo Health, Priya Bathija encourages healthcare leaders to ask questions, starting with, “How does this impact women differently?” Nyoo Health helps leaders align, inspire and execute initiatives that strengthen women’s health services and position their organizations at the forefront of care. In this conversation with McGuireWoods’ Micaela Enger and Gretchen Townshend, Priya reveals where returns on investment in women’s health truly lie — clinically, socially and economically.She also addresses persistent challenges such as payment disparities, the need for provider education across specialties and the importance of co-creating solutions between startups and health systems. As she explains, “There is an increased acknowledgement in the healthcare sector that women’s health needs to be a priority. After all, we’re 51% of the population.”Connect and Learn More☑️ Priya Bathija | LinkedIn☑️ Nyoo Health | LinkedIn | YouTube | Instagram☑️ Micaela Enger | LinkedIn☑️ Gretchen Townshend | LinkedIn☑️ Geoff Cockrell | LinkedIn☑️ McGuireWoods | LinkedIn | Facebook | Instagram | X☑️ Subscribe Apple Podcasts | Spotify | Amazon MusicThis podcast was recorded and is being made available by McGuireWoods for informational purposes only. By accessing this podcast, you acknowledge that McGuireWoods makes no warranty, guarantee, or representation as to the accuracy or sufficiency of the information featured in the podcast. The views, information, or opinions expressed during this podcast series are solely those of the individuals involved and do not necessarily reflect those of McGuireWoods. This podcast should not be used as a substitute for competent legal advice from a licensed professional attorney in your state and should not be construed as an offer to make or consider any investment or course of action.